nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—CXCL8—ovarian cancer	0.28	0.801	CbGaD
Indomethacin—ABCB1—ovarian cancer	0.0694	0.199	CbGaD
Indomethacin—SLCO1A2—Chlorambucil—ovarian cancer	0.0594	0.15	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—ovarian cancer	0.0555	0.14	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—ovarian cancer	0.0417	0.105	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—ovarian cancer	0.0326	0.0822	CbGbCtD
Indomethacin—ABCC1—Epirubicin—ovarian cancer	0.0232	0.0584	CbGbCtD
Indomethacin—ABCC1—Paclitaxel—ovarian cancer	0.0228	0.0576	CbGbCtD
Indomethacin—SLC22A7—Docetaxel—ovarian cancer	0.021	0.053	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—ovarian cancer	0.02	0.0506	CbGbCtD
Indomethacin—ABCC2—Paclitaxel—ovarian cancer	0.0169	0.0426	CbGbCtD
Indomethacin—ABCC1—Docetaxel—ovarian cancer	0.0165	0.0416	CbGbCtD
Indomethacin—ABCC2—Carboplatin—ovarian cancer	0.0159	0.0401	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—ovarian cancer	0.0123	0.031	CbGbCtD
Indomethacin—ABCC2—Docetaxel—ovarian cancer	0.0122	0.0308	CbGbCtD
Indomethacin—ABCB1—Topotecan—ovarian cancer	0.0111	0.0281	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—ovarian cancer	0.00911	0.023	CbGbCtD
Indomethacin—ABCB1—Vinorelbine—ovarian cancer	0.00784	0.0198	CbGbCtD
Indomethacin—CYP2C9—Paclitaxel—ovarian cancer	0.00568	0.0143	CbGbCtD
Indomethacin—ABCB1—Paclitaxel—ovarian cancer	0.00551	0.0139	CbGbCtD
Indomethacin—ABCB1—Docetaxel—ovarian cancer	0.00398	0.01	CbGbCtD
Indomethacin—ABCB1—Doxorubicin—ovarian cancer	0.00297	0.00749	CbGbCtD
Indomethacin—PTGS2—ovarian follicle—ovarian cancer	0.00196	0.0285	CbGeAlD
Indomethacin—PTGR2—myometrium—ovarian cancer	0.00183	0.0266	CbGeAlD
Indomethacin—PTGR2—embryo—ovarian cancer	0.00176	0.0255	CbGeAlD
Indomethacin—ABCC11—embryo—ovarian cancer	0.00174	0.0253	CbGeAlD
Indomethacin—PTGDR2—female reproductive system—ovarian cancer	0.00161	0.0233	CbGeAlD
Indomethacin—PTGR2—endometrium—ovarian cancer	0.00129	0.0187	CbGeAlD
Indomethacin—ABCC11—gonad—ovarian cancer	0.00118	0.0172	CbGeAlD
Indomethacin—GLO1—myometrium—ovarian cancer	0.00113	0.0164	CbGeAlD
Indomethacin—PPARG—Irinotecan—Topotecan—ovarian cancer	0.0011	0.405	CbGdCrCtD
Indomethacin—ABCC11—female reproductive system—ovarian cancer	0.00106	0.0153	CbGeAlD
Indomethacin—PLA2G2A—myometrium—ovarian cancer	0.00105	0.0153	CbGeAlD
Indomethacin—CXCL8—myometrium—ovarian cancer	0.00104	0.0151	CbGeAlD
Indomethacin—Tolmetin—CXCL8—ovarian cancer	0.00101	1	CrCbGaD
Indomethacin—PTGR2—female gonad—ovarian cancer	0.00097	0.0141	CbGeAlD
Indomethacin—PTGR2—vagina—ovarian cancer	0.000964	0.014	CbGeAlD
Indomethacin—ABCC11—female gonad—ovarian cancer	0.00096	0.0139	CbGeAlD
Indomethacin—PPARA—embryo—ovarian cancer	0.000943	0.0137	CbGeAlD
Indomethacin—PTGS1—oviduct—ovarian cancer	0.000901	0.0131	CbGeAlD
Indomethacin—AKR1C3—Vincristine—Vinorelbine—ovarian cancer	0.000898	0.33	CbGdCrCtD
Indomethacin—GLO1—epithelium—ovarian cancer	0.000887	0.0129	CbGeAlD
Indomethacin—GLO1—uterine cervix—ovarian cancer	0.000879	0.0128	CbGeAlD
Indomethacin—PTGR2—testis—ovarian cancer	0.00086	0.0125	CbGeAlD
Indomethacin—ABCC11—testis—ovarian cancer	0.000852	0.0124	CbGeAlD
Indomethacin—GLO1—decidua—ovarian cancer	0.000837	0.0122	CbGeAlD
Indomethacin—PLA2G2A—epithelium—ovarian cancer	0.000824	0.012	CbGeAlD
Indomethacin—AKR1C3—myometrium—ovarian cancer	0.000815	0.0118	CbGeAlD
Indomethacin—CXCL8—uterine cervix—ovarian cancer	0.000809	0.0117	CbGeAlD
Indomethacin—GLO1—endometrium—ovarian cancer	0.000795	0.0115	CbGeAlD
Indomethacin—PLA2G2A—decidua—ovarian cancer	0.000779	0.0113	CbGeAlD
Indomethacin—CXCL8—decidua—ovarian cancer	0.000771	0.0112	CbGeAlD
Indomethacin—PPARA—epithelium—ovarian cancer	0.00077	0.0112	CbGeAlD
Indomethacin—PLA2G2A—endometrium—ovarian cancer	0.000739	0.0107	CbGeAlD
Indomethacin—GLO1—gonad—ovarian cancer	0.000737	0.0107	CbGeAlD
Indomethacin—GLO1—uterus—ovarian cancer	0.000733	0.0106	CbGeAlD
Indomethacin—CXCL8—endometrium—ovarian cancer	0.000732	0.0106	CbGeAlD
Indomethacin—AKR1C3—Vinblastine—Vinorelbine—ovarian cancer	0.000722	0.265	CbGdCrCtD
Indomethacin—GLO1—female reproductive system—ovarian cancer	0.000659	0.00956	CbGeAlD
Indomethacin—AKR1C3—uterine cervix—ovarian cancer	0.000634	0.00921	CbGeAlD
Indomethacin—PTGR2—lymph node—ovarian cancer	0.000624	0.00906	CbGeAlD
Indomethacin—GLO1—bone marrow—ovarian cancer	0.000622	0.00903	CbGeAlD
Indomethacin—SLC10A1—gonad—ovarian cancer	0.000616	0.00894	CbGeAlD
Indomethacin—PLA2G2A—female reproductive system—ovarian cancer	0.000612	0.00889	CbGeAlD
Indomethacin—AKR1C3—decidua—ovarian cancer	0.000604	0.00878	CbGeAlD
Indomethacin—GLO1—female gonad—ovarian cancer	0.000599	0.0087	CbGeAlD
Indomethacin—GLO1—vagina—ovarian cancer	0.000596	0.00865	CbGeAlD
Indomethacin—AKR1C3—endometrium—ovarian cancer	0.000574	0.00833	CbGeAlD
Indomethacin—CXCL8—bone marrow—ovarian cancer	0.000572	0.00831	CbGeAlD
Indomethacin—PPARA—female reproductive system—ovarian cancer	0.000572	0.00831	CbGeAlD
Indomethacin—PLA2G2A—female gonad—ovarian cancer	0.000557	0.00809	CbGeAlD
Indomethacin—CXCL8—female gonad—ovarian cancer	0.000551	0.00801	CbGeAlD
Indomethacin—SLC10A1—female reproductive system—ovarian cancer	0.00055	0.00799	CbGeAlD
Indomethacin—CXCL8—vagina—ovarian cancer	0.000548	0.00796	CbGeAlD
Indomethacin—GLO1—testis—ovarian cancer	0.000531	0.00772	CbGeAlD
Indomethacin—AKR1C3—uterus—ovarian cancer	0.000529	0.00768	CbGeAlD
Indomethacin—PPARA—female gonad—ovarian cancer	0.00052	0.00756	CbGeAlD
Indomethacin—PPARG—embryo—ovarian cancer	0.000519	0.00753	CbGeAlD
Indomethacin—UGT2B7—female reproductive system—ovarian cancer	0.000515	0.00748	CbGeAlD
Indomethacin—SLC22A11—female reproductive system—ovarian cancer	0.000502	0.00729	CbGeAlD
Indomethacin—PLA2G2A—testis—ovarian cancer	0.000494	0.00718	CbGeAlD
Indomethacin—CXCL8—testis—ovarian cancer	0.000489	0.0071	CbGeAlD
Indomethacin—PPARA—testis—ovarian cancer	0.000462	0.0067	CbGeAlD
Indomethacin—AKR1C3—bone marrow—ovarian cancer	0.000449	0.00652	CbGeAlD
Indomethacin—SLC10A1—testis—ovarian cancer	0.000444	0.00645	CbGeAlD
Indomethacin—ABCC3—decidua—ovarian cancer	0.00044	0.00639	CbGeAlD
Indomethacin—AKR1C3—female gonad—ovarian cancer	0.000432	0.00628	CbGeAlD
Indomethacin—AKR1C3—vagina—ovarian cancer	0.00043	0.00624	CbGeAlD
Indomethacin—CES1—female reproductive system—ovarian cancer	0.000424	0.00616	CbGeAlD
Indomethacin—PPARG—epithelium—ovarian cancer	0.000423	0.00615	CbGeAlD
Indomethacin—ABCC1—myometrium—ovarian cancer	0.000418	0.00607	CbGeAlD
Indomethacin—UGT2B7—testis—ovarian cancer	0.000416	0.00604	CbGeAlD
Indomethacin—PPARG—decidua—ovarian cancer	0.0004	0.00581	CbGeAlD
Indomethacin—SLC22A7—testis—ovarian cancer	0.000396	0.00575	CbGeAlD
Indomethacin—CES1—female gonad—ovarian cancer	0.000386	0.00561	CbGeAlD
Indomethacin—GLO1—lymph node—ovarian cancer	0.000385	0.0056	CbGeAlD
Indomethacin—AKR1C3—testis—ovarian cancer	0.000383	0.00557	CbGeAlD
Indomethacin—SLCO1B1—female reproductive system—ovarian cancer	0.000365	0.0053	CbGeAlD
Indomethacin—PLA2G2A—lymph node—ovarian cancer	0.000358	0.0052	CbGeAlD
Indomethacin—CXCL8—lymph node—ovarian cancer	0.000355	0.00515	CbGeAlD
Indomethacin—PPARG—uterus—ovarian cancer	0.00035	0.00508	CbGeAlD
Indomethacin—ABCC3—female reproductive system—ovarian cancer	0.000346	0.00502	CbGeAlD
Indomethacin—CES1—testis—ovarian cancer	0.000342	0.00497	CbGeAlD
Indomethacin—PPARA—lymph node—ovarian cancer	0.000335	0.00486	CbGeAlD
Indomethacin—ABCC1—uterine cervix—ovarian cancer	0.000325	0.00472	CbGeAlD
Indomethacin—ABCC4—uterus—ovarian cancer	0.000318	0.00461	CbGeAlD
Indomethacin—ABCC3—female gonad—ovarian cancer	0.000315	0.00457	CbGeAlD
Indomethacin—PPARG—female reproductive system—ovarian cancer	0.000314	0.00457	CbGeAlD
Indomethacin—ABCC1—decidua—ovarian cancer	0.00031	0.0045	CbGeAlD
Indomethacin—PPARG—bone marrow—ovarian cancer	0.000297	0.00431	CbGeAlD
Indomethacin—ABCC1—endometrium—ovarian cancer	0.000294	0.00427	CbGeAlD
Indomethacin—PPARG—female gonad—ovarian cancer	0.000286	0.00416	CbGeAlD
Indomethacin—ABCC4—female reproductive system—ovarian cancer	0.000286	0.00415	CbGeAlD
Indomethacin—PPARG—vagina—ovarian cancer	0.000284	0.00413	CbGeAlD
Indomethacin—ABCC3—testis—ovarian cancer	0.000279	0.00405	CbGeAlD
Indomethacin—AKR1C3—lymph node—ovarian cancer	0.000278	0.00404	CbGeAlD
Indomethacin—ABCC2—female reproductive system—ovarian cancer	0.000276	0.00401	CbGeAlD
Indomethacin—PTGS2—myometrium—ovarian cancer	0.000276	0.004	CbGeAlD
Indomethacin—ABCC1—uterus—ovarian cancer	0.000271	0.00393	CbGeAlD
Indomethacin—ABCC4—bone marrow—ovarian cancer	0.00027	0.00392	CbGeAlD
Indomethacin—PTGS2—embryo—ovarian cancer	0.000265	0.00385	CbGeAlD
Indomethacin—ABCC4—female gonad—ovarian cancer	0.00026	0.00377	CbGeAlD
Indomethacin—PPARG—testis—ovarian cancer	0.000254	0.00369	CbGeAlD
Indomethacin—CES1—lymph node—ovarian cancer	0.000248	0.00361	CbGeAlD
Indomethacin—SLCO1A2—testis—ovarian cancer	0.000239	0.00348	CbGeAlD
Indomethacin—ALB—testis—ovarian cancer	0.000238	0.00346	CbGeAlD
Indomethacin—ABCC4—testis—ovarian cancer	0.00023	0.00335	CbGeAlD
Indomethacin—PTGS1—epithelium—ovarian cancer	0.000226	0.00329	CbGeAlD
Indomethacin—PTGS1—uterine cervix—ovarian cancer	0.000224	0.00326	CbGeAlD
Indomethacin—ABCC2—testis—ovarian cancer	0.000223	0.00324	CbGeAlD
Indomethacin—ABCC1—female gonad—ovarian cancer	0.000222	0.00322	CbGeAlD
Indomethacin—ABCC1—vagina—ovarian cancer	0.00022	0.0032	CbGeAlD
Indomethacin—PTGS2—epithelium—ovarian cancer	0.000216	0.00314	CbGeAlD
Indomethacin—CYP2C19—vagina—ovarian cancer	0.000215	0.00312	CbGeAlD
Indomethacin—PTGS2—uterine cervix—ovarian cancer	0.000214	0.00312	CbGeAlD
Indomethacin—PTGS1—endometrium—ovarian cancer	0.000203	0.00295	CbGeAlD
Indomethacin—ABCC3—lymph node—ovarian cancer	0.000202	0.00294	CbGeAlD
Indomethacin—ABCC1—testis—ovarian cancer	0.000196	0.00285	CbGeAlD
Indomethacin—PTGS2—endometrium—ovarian cancer	0.000194	0.00282	CbGeAlD
Indomethacin—PTGS1—uterus—ovarian cancer	0.000187	0.00272	CbGeAlD
Indomethacin—CYP2C9—female reproductive system—ovarian cancer	0.000184	0.00267	CbGeAlD
Indomethacin—PPARG—lymph node—ovarian cancer	0.000184	0.00267	CbGeAlD
Indomethacin—PTGS2—uterus—ovarian cancer	0.000179	0.0026	CbGeAlD
Indomethacin—ALB—lymph node—ovarian cancer	0.000173	0.00251	CbGeAlD
Indomethacin—ABCB1—myometrium—ovarian cancer	0.00017	0.00248	CbGeAlD
Indomethacin—PTGS1—female reproductive system—ovarian cancer	0.000168	0.00244	CbGeAlD
Indomethacin—ABCC4—lymph node—ovarian cancer	0.000167	0.00243	CbGeAlD
Indomethacin—ABCB1—embryo—ovarian cancer	0.000164	0.00238	CbGeAlD
Indomethacin—ABCC2—lymph node—ovarian cancer	0.000162	0.00235	CbGeAlD
Indomethacin—PTGS2—female reproductive system—ovarian cancer	0.000161	0.00233	CbGeAlD
Indomethacin—PTGS1—female gonad—ovarian cancer	0.000153	0.00222	CbGeAlD
Indomethacin—PTGS1—vagina—ovarian cancer	0.000152	0.00221	CbGeAlD
Indomethacin—PTGS2—bone marrow—ovarian cancer	0.000152	0.0022	CbGeAlD
Indomethacin—PTGS2—female gonad—ovarian cancer	0.000146	0.00212	CbGeAlD
Indomethacin—PTGS2—vagina—ovarian cancer	0.000145	0.00211	CbGeAlD
Indomethacin—ABCC1—lymph node—ovarian cancer	0.000142	0.00207	CbGeAlD
Indomethacin—PTGS1—testis—ovarian cancer	0.000136	0.00197	CbGeAlD
Indomethacin—ABCB1—epithelium—ovarian cancer	0.000134	0.00194	CbGeAlD
Indomethacin—ABCB1—uterine cervix—ovarian cancer	0.000133	0.00193	CbGeAlD
Indomethacin—ABCB1—decidua—ovarian cancer	0.000126	0.00184	CbGeAlD
Indomethacin—ABCB1—endometrium—ovarian cancer	0.00012	0.00174	CbGeAlD
Indomethacin—ABCB1—gonad—ovarian cancer	0.000111	0.00162	CbGeAlD
Indomethacin—ABCB1—uterus—ovarian cancer	0.000111	0.00161	CbGeAlD
Indomethacin—ABCB1—female reproductive system—ovarian cancer	9.94e-05	0.00144	CbGeAlD
Indomethacin—PTGS1—lymph node—ovarian cancer	9.83e-05	0.00143	CbGeAlD
Indomethacin—Arrhythmia—Docetaxel—ovarian cancer	9.65e-05	0.000865	CcSEcCtD
Indomethacin—Abdominal pain upper—Epirubicin—ovarian cancer	9.62e-05	0.000862	CcSEcCtD
Indomethacin—Convulsion—Paclitaxel—ovarian cancer	9.61e-05	0.000861	CcSEcCtD
Indomethacin—Hypertension—Paclitaxel—ovarian cancer	9.58e-05	0.000858	CcSEcCtD
Indomethacin—Alopecia—Docetaxel—ovarian cancer	9.55e-05	0.000855	CcSEcCtD
Indomethacin—Pruritus—Vinorelbine—ovarian cancer	9.52e-05	0.000854	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	9.48e-05	0.00085	CcSEcCtD
Indomethacin—Chest pain—Paclitaxel—ovarian cancer	9.45e-05	0.000846	CcSEcCtD
Indomethacin—Anxiety—Paclitaxel—ovarian cancer	9.41e-05	0.000844	CcSEcCtD
Indomethacin—Erythema—Docetaxel—ovarian cancer	9.4e-05	0.000843	CcSEcCtD
Indomethacin—PTGS2—lymph node—ovarian cancer	9.4e-05	0.00137	CbGeAlD
Indomethacin—ABCB1—bone marrow—ovarian cancer	9.38e-05	0.00136	CbGeAlD
Indomethacin—Nausea—Topotecan—ovarian cancer	9.35e-05	0.000838	CcSEcCtD
Indomethacin—Discomfort—Paclitaxel—ovarian cancer	9.33e-05	0.000836	CcSEcCtD
Indomethacin—Gastritis—Epirubicin—ovarian cancer	9.32e-05	0.000835	CcSEcCtD
Indomethacin—Muscular weakness—Epirubicin—ovarian cancer	9.29e-05	0.000832	CcSEcCtD
Indomethacin—Diarrhoea—Vinorelbine—ovarian cancer	9.21e-05	0.000825	CcSEcCtD
Indomethacin—Abdominal distension—Epirubicin—ovarian cancer	9.16e-05	0.000821	CcSEcCtD
Indomethacin—Nausea—Melphalan—ovarian cancer	9.15e-05	0.00082	CcSEcCtD
Indomethacin—Confusional state—Paclitaxel—ovarian cancer	9.13e-05	0.000818	CcSEcCtD
Indomethacin—Asthma—Epirubicin—ovarian cancer	9.1e-05	0.000816	CcSEcCtD
Indomethacin—Oedema—Paclitaxel—ovarian cancer	9.06e-05	0.000811	CcSEcCtD
Indomethacin—Anaphylactic shock—Paclitaxel—ovarian cancer	9.06e-05	0.000811	CcSEcCtD
Indomethacin—ABCB1—female gonad—ovarian cancer	9.04e-05	0.00131	CbGeAlD
Indomethacin—ABCB1—vagina—ovarian cancer	8.99e-05	0.00131	CbGeAlD
Indomethacin—Shock—Paclitaxel—ovarian cancer	8.91e-05	0.000798	CcSEcCtD
Indomethacin—Dizziness—Vinorelbine—ovarian cancer	8.9e-05	0.000798	CcSEcCtD
Indomethacin—Abdominal pain upper—Doxorubicin—ovarian cancer	8.9e-05	0.000798	CcSEcCtD
Indomethacin—Thrombocytopenia—Paclitaxel—ovarian cancer	8.87e-05	0.000795	CcSEcCtD
Indomethacin—Tachycardia—Paclitaxel—ovarian cancer	8.84e-05	0.000792	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	8.78e-05	0.000786	CcSEcCtD
Indomethacin—Hyperhidrosis—Paclitaxel—ovarian cancer	8.75e-05	0.000784	CcSEcCtD
Indomethacin—Anaemia—Docetaxel—ovarian cancer	8.69e-05	0.000779	CcSEcCtD
Indomethacin—Pancytopenia—Epirubicin—ovarian cancer	8.65e-05	0.000775	CcSEcCtD
Indomethacin—Anorexia—Paclitaxel—ovarian cancer	8.63e-05	0.000774	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—ovarian cancer	8.63e-05	0.000773	CcSEcCtD
Indomethacin—Muscular weakness—Doxorubicin—ovarian cancer	8.6e-05	0.00077	CcSEcCtD
Indomethacin—Vomiting—Vinorelbine—ovarian cancer	8.56e-05	0.000767	CcSEcCtD
Indomethacin—Rash—Vinorelbine—ovarian cancer	8.49e-05	0.000761	CcSEcCtD
Indomethacin—Dermatitis—Vinorelbine—ovarian cancer	8.48e-05	0.00076	CcSEcCtD
Indomethacin—Abdominal distension—Doxorubicin—ovarian cancer	8.48e-05	0.00076	CcSEcCtD
Indomethacin—Hypotension—Paclitaxel—ovarian cancer	8.46e-05	0.000758	CcSEcCtD
Indomethacin—Headache—Vinorelbine—ovarian cancer	8.43e-05	0.000756	CcSEcCtD
Indomethacin—Syncope—Docetaxel—ovarian cancer	8.43e-05	0.000756	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—ovarian cancer	8.42e-05	0.000755	CcSEcCtD
Indomethacin—Leukopenia—Docetaxel—ovarian cancer	8.42e-05	0.000754	CcSEcCtD
Indomethacin—Pollakiuria—Epirubicin—ovarian cancer	8.41e-05	0.000754	CcSEcCtD
Indomethacin—Palpitations—Docetaxel—ovarian cancer	8.31e-05	0.000745	CcSEcCtD
Indomethacin—Weight increased—Epirubicin—ovarian cancer	8.28e-05	0.000742	CcSEcCtD
Indomethacin—Loss of consciousness—Docetaxel—ovarian cancer	8.27e-05	0.000741	CcSEcCtD
Indomethacin—Hyperglycaemia—Epirubicin—ovarian cancer	8.21e-05	0.000736	CcSEcCtD
Indomethacin—Insomnia—Paclitaxel—ovarian cancer	8.19e-05	0.000734	CcSEcCtD
Indomethacin—Convulsion—Docetaxel—ovarian cancer	8.15e-05	0.00073	CcSEcCtD
Indomethacin—Paraesthesia—Paclitaxel—ovarian cancer	8.13e-05	0.000729	CcSEcCtD
Indomethacin—Hypertension—Docetaxel—ovarian cancer	8.12e-05	0.000728	CcSEcCtD
Indomethacin—Drowsiness—Epirubicin—ovarian cancer	8.12e-05	0.000727	CcSEcCtD
Indomethacin—Dyspnoea—Paclitaxel—ovarian cancer	8.07e-05	0.000723	CcSEcCtD
Indomethacin—Somnolence—Paclitaxel—ovarian cancer	8.05e-05	0.000721	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	8.05e-05	0.000721	CcSEcCtD
Indomethacin—ABCB1—testis—ovarian cancer	8.02e-05	0.00117	CbGeAlD
Indomethacin—Chest pain—Docetaxel—ovarian cancer	8.01e-05	0.000717	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—ovarian cancer	8e-05	0.000717	CcSEcCtD
Indomethacin—Nausea—Vinorelbine—ovarian cancer	8e-05	0.000717	CcSEcCtD
Indomethacin—Renal failure—Epirubicin—ovarian cancer	7.98e-05	0.000715	CcSEcCtD
Indomethacin—Dyspepsia—Paclitaxel—ovarian cancer	7.97e-05	0.000714	CcSEcCtD
Indomethacin—Neuropathy peripheral—Epirubicin—ovarian cancer	7.96e-05	0.000713	CcSEcCtD
Indomethacin—Jaundice—Epirubicin—ovarian cancer	7.91e-05	0.000709	CcSEcCtD
Indomethacin—Stomatitis—Epirubicin—ovarian cancer	7.91e-05	0.000709	CcSEcCtD
Indomethacin—Decreased appetite—Paclitaxel—ovarian cancer	7.87e-05	0.000705	CcSEcCtD
Indomethacin—Fatigue—Paclitaxel—ovarian cancer	7.81e-05	0.0007	CcSEcCtD
Indomethacin—Sweating—Epirubicin—ovarian cancer	7.78e-05	0.000697	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—ovarian cancer	7.78e-05	0.000697	CcSEcCtD
Indomethacin—Pain—Paclitaxel—ovarian cancer	7.74e-05	0.000694	CcSEcCtD
Indomethacin—Constipation—Paclitaxel—ovarian cancer	7.74e-05	0.000694	CcSEcCtD
Indomethacin—Haematuria—Epirubicin—ovarian cancer	7.74e-05	0.000694	CcSEcCtD
Indomethacin—Confusional state—Docetaxel—ovarian cancer	7.74e-05	0.000694	CcSEcCtD
Indomethacin—Oedema—Docetaxel—ovarian cancer	7.68e-05	0.000688	CcSEcCtD
Indomethacin—Anaphylactic shock—Docetaxel—ovarian cancer	7.68e-05	0.000688	CcSEcCtD
Indomethacin—Weight increased—Doxorubicin—ovarian cancer	7.67e-05	0.000687	CcSEcCtD
Indomethacin—Epistaxis—Epirubicin—ovarian cancer	7.66e-05	0.000686	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—ovarian cancer	7.6e-05	0.000681	CcSEcCtD
Indomethacin—Agranulocytosis—Epirubicin—ovarian cancer	7.57e-05	0.000679	CcSEcCtD
Indomethacin—Shock—Docetaxel—ovarian cancer	7.55e-05	0.000677	CcSEcCtD
Indomethacin—Thrombocytopenia—Docetaxel—ovarian cancer	7.51e-05	0.000673	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—ovarian cancer	7.51e-05	0.000673	CcSEcCtD
Indomethacin—Tachycardia—Docetaxel—ovarian cancer	7.49e-05	0.000671	CcSEcCtD
Indomethacin—Feeling abnormal—Paclitaxel—ovarian cancer	7.46e-05	0.000669	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	7.45e-05	0.000667	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—ovarian cancer	7.42e-05	0.000665	CcSEcCtD
Indomethacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	7.4e-05	0.000664	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—ovarian cancer	7.38e-05	0.000662	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.36e-05	0.00066	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—ovarian cancer	7.32e-05	0.000656	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—ovarian cancer	7.32e-05	0.000656	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—ovarian cancer	7.32e-05	0.000656	CcSEcCtD
Indomethacin—Anorexia—Docetaxel—ovarian cancer	7.32e-05	0.000656	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—ovarian cancer	7.29e-05	0.000653	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—ovarian cancer	7.29e-05	0.000653	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—ovarian cancer	7.2e-05	0.000645	CcSEcCtD
Indomethacin—Urticaria—Paclitaxel—ovarian cancer	7.19e-05	0.000645	CcSEcCtD
Indomethacin—Hypotension—Docetaxel—ovarian cancer	7.17e-05	0.000643	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—ovarian cancer	7.16e-05	0.000642	CcSEcCtD
Indomethacin—Abdominal pain—Paclitaxel—ovarian cancer	7.16e-05	0.000641	CcSEcCtD
Indomethacin—Body temperature increased—Paclitaxel—ovarian cancer	7.16e-05	0.000641	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—ovarian cancer	7.08e-05	0.000635	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—ovarian cancer	7.01e-05	0.000628	CcSEcCtD
Indomethacin—Insomnia—Docetaxel—ovarian cancer	6.94e-05	0.000622	CcSEcCtD
Indomethacin—Paraesthesia—Docetaxel—ovarian cancer	6.89e-05	0.000618	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—ovarian cancer	6.89e-05	0.000617	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—ovarian cancer	6.86e-05	0.000615	CcSEcCtD
Indomethacin—Dyspnoea—Docetaxel—ovarian cancer	6.84e-05	0.000613	CcSEcCtD
Indomethacin—Somnolence—Docetaxel—ovarian cancer	6.82e-05	0.000611	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—ovarian cancer	6.79e-05	0.000609	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—ovarian cancer	6.78e-05	0.000607	CcSEcCtD
Indomethacin—Flushing—Epirubicin—ovarian cancer	6.76e-05	0.000606	CcSEcCtD
Indomethacin—Dyspepsia—Docetaxel—ovarian cancer	6.76e-05	0.000605	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—ovarian cancer	6.74e-05	0.000604	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—ovarian cancer	6.74e-05	0.000604	CcSEcCtD
Indomethacin—Decreased appetite—Docetaxel—ovarian cancer	6.67e-05	0.000598	CcSEcCtD
Indomethacin—Hypersensitivity—Paclitaxel—ovarian cancer	6.67e-05	0.000598	CcSEcCtD
Indomethacin—Fatigue—Docetaxel—ovarian cancer	6.62e-05	0.000593	CcSEcCtD
Indomethacin—Constipation—Docetaxel—ovarian cancer	6.56e-05	0.000588	CcSEcCtD
Indomethacin—Pain—Docetaxel—ovarian cancer	6.56e-05	0.000588	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—ovarian cancer	6.51e-05	0.000583	CcSEcCtD
Indomethacin—Asthenia—Paclitaxel—ovarian cancer	6.5e-05	0.000582	CcSEcCtD
Indomethacin—Alopecia—Epirubicin—ovarian cancer	6.44e-05	0.000577	CcSEcCtD
Indomethacin—Pruritus—Paclitaxel—ovarian cancer	6.41e-05	0.000574	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—ovarian cancer	6.37e-05	0.000571	CcSEcCtD
Indomethacin—Erythema—Epirubicin—ovarian cancer	6.34e-05	0.000568	CcSEcCtD
Indomethacin—Feeling abnormal—Docetaxel—ovarian cancer	6.32e-05	0.000567	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—ovarian cancer	6.29e-05	0.000563	CcSEcCtD
Indomethacin—Gastrointestinal pain—Docetaxel—ovarian cancer	6.28e-05	0.000562	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—ovarian cancer	6.26e-05	0.000561	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—ovarian cancer	6.25e-05	0.00056	CcSEcCtD
Indomethacin—Tension—Epirubicin—ovarian cancer	6.22e-05	0.000558	CcSEcCtD
Indomethacin—Diarrhoea—Paclitaxel—ovarian cancer	6.2e-05	0.000555	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—ovarian cancer	6.16e-05	0.000552	CcSEcCtD
Indomethacin—Abdominal pain—Docetaxel—ovarian cancer	6.07e-05	0.000544	CcSEcCtD
Indomethacin—Body temperature increased—Docetaxel—ovarian cancer	6.07e-05	0.000544	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—ovarian cancer	6.02e-05	0.00054	CcSEcCtD
Indomethacin—Dizziness—Paclitaxel—ovarian cancer	5.99e-05	0.000537	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—ovarian cancer	5.98e-05	0.000536	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—ovarian cancer	5.96e-05	0.000534	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—ovarian cancer	5.89e-05	0.000527	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—ovarian cancer	5.87e-05	0.000526	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—ovarian cancer	5.86e-05	0.000525	CcSEcCtD
Indomethacin—ABCB1—lymph node—ovarian cancer	5.81e-05	0.000845	CbGeAlD
Indomethacin—Flatulence—Doxorubicin—ovarian cancer	5.78e-05	0.000518	CcSEcCtD
Indomethacin—Tension—Doxorubicin—ovarian cancer	5.76e-05	0.000516	CcSEcCtD
Indomethacin—Vomiting—Paclitaxel—ovarian cancer	5.76e-05	0.000516	CcSEcCtD
Indomethacin—Malaise—Epirubicin—ovarian cancer	5.72e-05	0.000513	CcSEcCtD
Indomethacin—Rash—Paclitaxel—ovarian cancer	5.71e-05	0.000512	CcSEcCtD
Indomethacin—Dermatitis—Paclitaxel—ovarian cancer	5.7e-05	0.000511	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—ovarian cancer	5.7e-05	0.000511	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—ovarian cancer	5.7e-05	0.000511	CcSEcCtD
Indomethacin—Syncope—Epirubicin—ovarian cancer	5.69e-05	0.00051	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—ovarian cancer	5.68e-05	0.000509	CcSEcCtD
Indomethacin—Headache—Paclitaxel—ovarian cancer	5.67e-05	0.000508	CcSEcCtD
Indomethacin—Hypersensitivity—Docetaxel—ovarian cancer	5.65e-05	0.000507	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—ovarian cancer	5.61e-05	0.000502	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—ovarian cancer	5.58e-05	0.0005	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—ovarian cancer	5.53e-05	0.000496	CcSEcCtD
Indomethacin—Asthenia—Docetaxel—ovarian cancer	5.51e-05	0.000493	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—ovarian cancer	5.5e-05	0.000493	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—ovarian cancer	5.48e-05	0.000491	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—ovarian cancer	5.45e-05	0.000488	CcSEcCtD
Indomethacin—Pruritus—Docetaxel—ovarian cancer	5.43e-05	0.000487	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—ovarian cancer	5.42e-05	0.000486	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—ovarian cancer	5.4e-05	0.000484	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—ovarian cancer	5.38e-05	0.000482	CcSEcCtD
Indomethacin—Nausea—Paclitaxel—ovarian cancer	5.38e-05	0.000482	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—ovarian cancer	5.34e-05	0.000478	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—ovarian cancer	5.29e-05	0.000474	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—ovarian cancer	5.27e-05	0.000473	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—ovarian cancer	5.26e-05	0.000472	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—ovarian cancer	5.25e-05	0.000471	CcSEcCtD
Indomethacin—Diarrhoea—Docetaxel—ovarian cancer	5.25e-05	0.000471	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—ovarian cancer	5.22e-05	0.000468	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—ovarian cancer	5.19e-05	0.000465	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—ovarian cancer	5.18e-05	0.000464	CcSEcCtD
Indomethacin—Oedema—Epirubicin—ovarian cancer	5.18e-05	0.000464	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—ovarian cancer	5.16e-05	0.000462	CcSEcCtD
Indomethacin—Shock—Epirubicin—ovarian cancer	5.09e-05	0.000456	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—ovarian cancer	5.09e-05	0.000456	CcSEcCtD
Indomethacin—Dizziness—Docetaxel—ovarian cancer	5.08e-05	0.000455	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—ovarian cancer	5.07e-05	0.000454	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—ovarian cancer	5.07e-05	0.000454	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—ovarian cancer	5.05e-05	0.000453	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—ovarian cancer	5e-05	0.000448	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—ovarian cancer	5e-05	0.000448	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—ovarian cancer	4.98e-05	0.000446	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—ovarian cancer	4.94e-05	0.000442	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—ovarian cancer	4.93e-05	0.000442	CcSEcCtD
Indomethacin—Vomiting—Docetaxel—ovarian cancer	4.88e-05	0.000437	CcSEcCtD
Indomethacin—Rash—Docetaxel—ovarian cancer	4.84e-05	0.000434	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—ovarian cancer	4.84e-05	0.000434	CcSEcCtD
Indomethacin—Dermatitis—Docetaxel—ovarian cancer	4.83e-05	0.000433	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—ovarian cancer	4.83e-05	0.000433	CcSEcCtD
Indomethacin—Headache—Docetaxel—ovarian cancer	4.81e-05	0.000431	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—ovarian cancer	4.79e-05	0.000429	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—ovarian cancer	4.79e-05	0.000429	CcSEcCtD
Indomethacin—Shock—Doxorubicin—ovarian cancer	4.71e-05	0.000422	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—ovarian cancer	4.69e-05	0.00042	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—ovarian cancer	4.68e-05	0.00042	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—ovarian cancer	4.67e-05	0.000419	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—ovarian cancer	4.65e-05	0.000417	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—ovarian cancer	4.63e-05	0.000415	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—ovarian cancer	4.62e-05	0.000414	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—ovarian cancer	4.6e-05	0.000412	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—ovarian cancer	4.57e-05	0.000409	CcSEcCtD
Indomethacin—Nausea—Docetaxel—ovarian cancer	4.56e-05	0.000409	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—ovarian cancer	4.56e-05	0.000408	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—ovarian cancer	4.5e-05	0.000403	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—ovarian cancer	4.48e-05	0.000401	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—ovarian cancer	4.46e-05	0.0004	CcSEcCtD
Indomethacin—Constipation—Epirubicin—ovarian cancer	4.43e-05	0.000397	CcSEcCtD
Indomethacin—Pain—Epirubicin—ovarian cancer	4.43e-05	0.000397	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—ovarian cancer	4.33e-05	0.000388	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—ovarian cancer	4.3e-05	0.000385	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—ovarian cancer	4.27e-05	0.000383	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—ovarian cancer	4.27e-05	0.000382	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—ovarian cancer	4.26e-05	0.000382	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—ovarian cancer	4.23e-05	0.000379	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—ovarian cancer	4.22e-05	0.000378	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—ovarian cancer	4.16e-05	0.000373	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—ovarian cancer	4.13e-05	0.00037	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—ovarian cancer	4.11e-05	0.000369	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—ovarian cancer	4.1e-05	0.000367	CcSEcCtD
Indomethacin—Pain—Doxorubicin—ovarian cancer	4.1e-05	0.000367	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—ovarian cancer	4.09e-05	0.000367	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—ovarian cancer	4.09e-05	0.000367	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—ovarian cancer	3.95e-05	0.000354	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.92e-05	0.000351	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—ovarian cancer	3.81e-05	0.000342	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—ovarian cancer	3.81e-05	0.000341	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—ovarian cancer	3.79e-05	0.000339	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—ovarian cancer	3.79e-05	0.000339	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—ovarian cancer	3.71e-05	0.000333	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—ovarian cancer	3.66e-05	0.000328	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—ovarian cancer	3.54e-05	0.000317	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—ovarian cancer	3.53e-05	0.000316	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—ovarian cancer	3.44e-05	0.000308	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—ovarian cancer	3.42e-05	0.000307	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—ovarian cancer	3.39e-05	0.000304	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—ovarian cancer	3.29e-05	0.000295	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—ovarian cancer	3.28e-05	0.000294	CcSEcCtD
Indomethacin—Rash—Epirubicin—ovarian cancer	3.26e-05	0.000293	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—ovarian cancer	3.26e-05	0.000292	CcSEcCtD
Indomethacin—Headache—Epirubicin—ovarian cancer	3.24e-05	0.000291	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—ovarian cancer	3.17e-05	0.000284	CcSEcCtD
Indomethacin—Nausea—Epirubicin—ovarian cancer	3.07e-05	0.000276	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—ovarian cancer	3.05e-05	0.000273	CcSEcCtD
Indomethacin—Rash—Doxorubicin—ovarian cancer	3.02e-05	0.000271	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—ovarian cancer	3.02e-05	0.00027	CcSEcCtD
Indomethacin—Headache—Doxorubicin—ovarian cancer	3e-05	0.000269	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—ovarian cancer	2.85e-05	0.000255	CcSEcCtD
Indomethacin—ABCC1—Metabolism—CAV1—ovarian cancer	5.21e-06	7.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.2e-06	7.4e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.19e-06	7.39e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.16e-06	7.34e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PIK3CA—ovarian cancer	5.14e-06	7.31e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—ovarian cancer	5.13e-06	7.3e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—YAP1—ovarian cancer	5.12e-06	7.29e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTEN—ovarian cancer	5.1e-06	7.26e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.08e-06	7.24e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CD—ovarian cancer	5.03e-06	7.16e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PIK3CA—ovarian cancer	5e-06	7.12e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CD—ovarian cancer	4.98e-06	7.09e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.97e-06	7.08e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CAV1—ovarian cancer	4.95e-06	7.04e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CG—ovarian cancer	4.92e-06	7e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CG—ovarian cancer	4.92e-06	7e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CB—ovarian cancer	4.87e-06	6.93e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—ovarian cancer	4.81e-06	6.84e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PIK3CA—ovarian cancer	4.8e-06	6.84e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—YAP1—ovarian cancer	4.78e-06	6.81e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—FASN—ovarian cancer	4.76e-06	6.78e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPP2R1A—ovarian cancer	4.76e-06	6.77e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—ovarian cancer	4.75e-06	6.77e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CG—ovarian cancer	4.74e-06	6.75e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.73e-06	6.74e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.73e-06	6.74e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.73e-06	6.73e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ERBB2—ovarian cancer	4.72e-06	6.72e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	4.7e-06	6.69e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC5A5—ovarian cancer	4.68e-06	6.67e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MTOR—ovarian cancer	4.66e-06	6.63e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CB—ovarian cancer	4.66e-06	6.63e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CB—ovarian cancer	4.64e-06	6.6e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CB—ovarian cancer	4.64e-06	6.6e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	4.63e-06	6.6e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.63e-06	6.59e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—ovarian cancer	4.61e-06	6.56e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.56e-06	6.5e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STAT3—ovarian cancer	4.56e-06	6.49e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRAS—ovarian cancer	4.55e-06	6.48e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—ovarian cancer	4.55e-06	6.48e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC2A1—ovarian cancer	4.52e-06	6.44e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TERT—ovarian cancer	4.51e-06	6.42e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	4.51e-06	6.42e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2—ovarian cancer	4.47e-06	6.36e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—ovarian cancer	4.44e-06	6.33e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.43e-06	6.31e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ABCB1—ovarian cancer	4.42e-06	6.29e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CAV1—ovarian cancer	4.4e-06	6.27e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERBB2—ovarian cancer	4.4e-06	6.26e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CB—ovarian cancer	4.39e-06	6.24e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1B—ovarian cancer	4.37e-06	6.22e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK3—ovarian cancer	4.36e-06	6.2e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MTOR—ovarian cancer	4.34e-06	6.18e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CB—ovarian cancer	4.34e-06	6.18e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP1B1—ovarian cancer	4.34e-06	6.18e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TYMS—ovarian cancer	4.34e-06	6.17e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CD—ovarian cancer	4.32e-06	6.16e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CD—ovarian cancer	4.32e-06	6.16e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—ovarian cancer	4.32e-06	6.15e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—ovarian cancer	4.3e-06	6.13e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—ovarian cancer	4.28e-06	6.1e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—FASN—ovarian cancer	4.28e-06	6.09e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2—ovarian cancer	4.28e-06	6.09e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—ovarian cancer	4.25e-06	6.06e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—ovarian cancer	4.24e-06	6.03e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC5A5—ovarian cancer	4.21e-06	5.99e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.21e-06	5.99e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—ovarian cancer	4.2e-06	5.97e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—FASN—ovarian cancer	4.17e-06	5.94e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CAV1—ovarian cancer	4.17e-06	5.94e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CD—ovarian cancer	4.17e-06	5.94e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—ovarian cancer	4.17e-06	5.93e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MAPK3—ovarian cancer	4.16e-06	5.93e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.16e-06	5.92e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK1—ovarian cancer	4.15e-06	5.9e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—ovarian cancer	4.14e-06	5.9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CTNNB1—ovarian cancer	4.13e-06	5.88e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC5A5—ovarian cancer	4.1e-06	5.84e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—ovarian cancer	4.09e-06	5.82e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1B—ovarian cancer	4.07e-06	5.8e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC2A1—ovarian cancer	4.06e-06	5.78e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—ovarian cancer	4.05e-06	5.77e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—ovarian cancer	4.05e-06	5.76e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	4.04e-06	5.75e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—ovarian cancer	4.02e-06	5.73e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CG—ovarian cancer	4.01e-06	5.71e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—ovarian cancer	4.01e-06	5.71e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—ovarian cancer	4.01e-06	5.71e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.98e-06	5.66e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC2A1—ovarian cancer	3.96e-06	5.64e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	3.96e-06	5.64e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6ST—ovarian cancer	3.96e-06	5.63e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—ovarian cancer	3.92e-06	5.59e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—ovarian cancer	3.92e-06	5.58e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—ovarian cancer	3.92e-06	5.57e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—FASN—ovarian cancer	3.9e-06	5.55e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1B1—ovarian cancer	3.89e-06	5.54e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPP2R1A—ovarian cancer	3.85e-06	5.48e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CTNNB1—ovarian cancer	3.85e-06	5.48e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC5A5—ovarian cancer	3.83e-06	5.46e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.83e-06	5.45e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1B1—ovarian cancer	3.8e-06	5.41e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APC—ovarian cancer	3.8e-06	5.41e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—ovarian cancer	3.8e-06	5.41e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—ovarian cancer	3.79e-06	5.39e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CB—ovarian cancer	3.77e-06	5.37e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CB—ovarian cancer	3.77e-06	5.37e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—ovarian cancer	3.75e-06	5.34e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—ovarian cancer	3.75e-06	5.34e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—ovarian cancer	3.73e-06	5.31e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A1—ovarian cancer	3.7e-06	5.27e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CB—ovarian cancer	3.63e-06	5.17e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—ovarian cancer	3.63e-06	5.17e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.63e-06	5.16e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—ovarian cancer	3.6e-06	5.12e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—ovarian cancer	3.6e-06	5.12e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK3—ovarian cancer	3.59e-06	5.12e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—ovarian cancer	3.59e-06	5.11e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCB1—ovarian cancer	3.57e-06	5.09e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1B1—ovarian cancer	3.55e-06	5.05e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CD—ovarian cancer	3.52e-06	5.02e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—ovarian cancer	3.51e-06	5e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TYMS—ovarian cancer	3.51e-06	4.99e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAV1—ovarian cancer	3.49e-06	4.97e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—ovarian cancer	3.49e-06	4.97e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—ovarian cancer	3.48e-06	4.95e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	3.45e-06	4.92e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	3.45e-06	4.92e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK3—ovarian cancer	3.44e-06	4.89e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.44e-06	4.89e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK1—ovarian cancer	3.42e-06	4.87e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPP2R1A—ovarian cancer	3.37e-06	4.8e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—ovarian cancer	3.35e-06	4.77e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—ovarian cancer	3.35e-06	4.76e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—ovarian cancer	3.34e-06	4.76e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CD—ovarian cancer	3.34e-06	4.76e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.34e-06	4.75e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—ovarian cancer	3.33e-06	4.74e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK1—ovarian cancer	3.27e-06	4.66e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—ovarian cancer	3.27e-06	4.65e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—ovarian cancer	3.26e-06	4.64e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—ovarian cancer	3.26e-06	4.64e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—ovarian cancer	3.23e-06	4.6e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCB1—ovarian cancer	3.21e-06	4.57e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK3—ovarian cancer	3.2e-06	4.56e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—ovarian cancer	3.19e-06	4.54e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CG—ovarian cancer	3.18e-06	4.53e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TYMS—ovarian cancer	3.15e-06	4.48e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.15e-06	4.48e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—ovarian cancer	3.14e-06	4.47e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.13e-06	4.46e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—ovarian cancer	3.12e-06	4.44e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—ovarian cancer	3.09e-06	4.4e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TYMS—ovarian cancer	3.07e-06	4.38e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CB—ovarian cancer	3.07e-06	4.37e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK1—ovarian cancer	3.05e-06	4.34e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—ovarian cancer	3.05e-06	4.34e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—ovarian cancer	3.05e-06	4.34e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—ovarian cancer	2.98e-06	4.25e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—ovarian cancer	2.97e-06	4.22e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—ovarian cancer	2.95e-06	4.2e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—ovarian cancer	2.94e-06	4.18e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCB1—ovarian cancer	2.92e-06	4.16e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTOR—ovarian cancer	2.91e-06	4.15e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CB—ovarian cancer	2.91e-06	4.15e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—ovarian cancer	2.88e-06	4.1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TYMS—ovarian cancer	2.87e-06	4.09e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—ovarian cancer	2.87e-06	4.09e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—ovarian cancer	2.84e-06	4.04e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—ovarian cancer	2.83e-06	4.02e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—ovarian cancer	2.83e-06	4.02e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAV1—ovarian cancer	2.83e-06	4.02e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—ovarian cancer	2.81e-06	4e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CD—ovarian cancer	2.8e-06	3.98e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—ovarian cancer	2.75e-06	3.91e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—ovarian cancer	2.74e-06	3.91e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1B—ovarian cancer	2.73e-06	3.89e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.7e-06	3.84e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—ovarian cancer	2.67e-06	3.81e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—ovarian cancer	2.65e-06	3.78e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—ovarian cancer	2.65e-06	3.77e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—ovarian cancer	2.63e-06	3.74e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CTNNB1—ovarian cancer	2.58e-06	3.68e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CG—ovarian cancer	2.57e-06	3.67e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAV1—ovarian cancer	2.54e-06	3.61e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—ovarian cancer	2.52e-06	3.58e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—ovarian cancer	2.51e-06	3.58e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAV1—ovarian cancer	2.48e-06	3.53e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	2.46e-06	3.5e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—ovarian cancer	2.45e-06	3.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CB—ovarian cancer	2.44e-06	3.47e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.42e-06	3.45e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—ovarian cancer	2.42e-06	3.45e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—ovarian cancer	2.34e-06	3.33e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—ovarian cancer	2.32e-06	3.3e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAV1—ovarian cancer	2.31e-06	3.29e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.31e-06	3.29e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—ovarian cancer	2.31e-06	3.29e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—ovarian cancer	2.31e-06	3.29e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—ovarian cancer	2.3e-06	3.27e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—ovarian cancer	2.3e-06	3.27e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CD—ovarian cancer	2.26e-06	3.22e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.26e-06	3.21e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—ovarian cancer	2.25e-06	3.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—ovarian cancer	2.24e-06	3.2e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—ovarian cancer	2.22e-06	3.15e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.21e-06	3.15e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—ovarian cancer	2.18e-06	3.11e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—ovarian cancer	2.16e-06	3.08e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK3—ovarian cancer	2.15e-06	3.06e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.11e-06	3e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—ovarian cancer	2.11e-06	3e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	2.11e-06	3e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—ovarian cancer	2.09e-06	2.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK1—ovarian cancer	2.05e-06	2.91e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—ovarian cancer	2.05e-06	2.91e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.03e-06	2.89e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—ovarian cancer	2.01e-06	2.86e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.98e-06	2.82e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CB—ovarian cancer	1.97e-06	2.81e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—ovarian cancer	1.93e-06	2.75e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—ovarian cancer	1.88e-06	2.67e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—ovarian cancer	1.88e-06	2.67e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—ovarian cancer	1.87e-06	2.67e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.85e-06	2.64e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—ovarian cancer	1.81e-06	2.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—ovarian cancer	1.78e-06	2.53e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.77e-06	2.52e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.73e-06	2.46e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—ovarian cancer	1.72e-06	2.45e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—ovarian cancer	1.7e-06	2.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—ovarian cancer	1.64e-06	2.34e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.61e-06	2.3e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—ovarian cancer	1.57e-06	2.24e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—ovarian cancer	1.53e-06	2.18e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—ovarian cancer	1.53e-06	2.18e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—ovarian cancer	1.49e-06	2.13e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—ovarian cancer	1.49e-06	2.12e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—ovarian cancer	1.45e-06	2.06e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—ovarian cancer	1.4e-06	1.99e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—ovarian cancer	1.21e-06	1.73e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—ovarian cancer	1.2e-06	1.71e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.08e-06	1.54e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.05e-06	1.5e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—ovarian cancer	9.84e-07	1.4e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—ovarian cancer	9.83e-07	1.4e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—ovarian cancer	8.82e-07	1.26e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—ovarian cancer	8.61e-07	1.23e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—ovarian cancer	8.04e-07	1.14e-05	CbGpPWpGaD
